Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid

Andrea Tedeschi, Piergiuseppe Agostoni, Beatrice Pezzuto, Ugo Corra’, Domenico Scrutinio, Rocco La Gioia, Rosa Raimondo, Andrea Passantino, Massimo F. Piepoli

Research output: Contribution to journalArticlepeer-review


Despite improvements in pharmacotherapy, morbidity and mortality rates in community-based populations with chronic heart failure still remain high. The increase in medical complexity among patients with heart failure may be reflected by an increase in concomitant non-cardiovascular comorbidities, which are recognized as independent prognostic factors in this population. Heart failure and chronic kidney disease share many risk factors, and often coexist. The presence of kidney failure is associated with incremented risk of cardiovascular and non-cardiovascular mortality in heart failure patients. Chronic kidney disease is also linked with underutilization of evidence-based heart failure therapy that may reduce morbidity and mortality. More targeted therapies would be important to improve the prognosis of patients with these diseases. In recent years, serum uric acid as a determinant of cardiovascular risk has gained interest. Epidemiological, experimental and clinical data show that patients with hyperuricaemia are at increased risk of cardiac, renal and vascular damage and cardiovascular events. Moreover, elevated serum uric acid predicts worse outcome in both acute and chronic heart failure. While studies have raised the possibility of preventing heart failure through the use of uric acid lowering agents, the literature is still inconclusive on whether the reduction in uric acid will result in a measurable clinical benefit. Available evidences suggest that chronic kidney disease and elevated uric acid could worsen heart failure patients’ prognosis. The aim of this review is to analyse a possible utilization of these comorbidities in risk stratification and as a therapeutic target to get a prognostic improvement in heart failure patients.

Original languageEnglish
Pages (from-to)35-45
Number of pages11
JournalEuropean Journal of Preventive Cardiology
Issue number2_suppl
Publication statusPublished - Dec 2020


  • comorbidities
  • Heart failure
  • kidney
  • prognosis
  • risk stratification
  • uric acid

ASJC Scopus subject areas

  • Epidemiology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid'. Together they form a unique fingerprint.

Cite this